rabbit anti-mouse-phospho-p38 (Cell Signaling Technology Inc)
Structured Review

Rabbit Anti Mouse Phospho P38, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-mouse-phospho-p38/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "p38 mitogen-activated protein kinase drives senescence in CD4 + T lymphocytes and increases their pathological potential"
Article Title: p38 mitogen-activated protein kinase drives senescence in CD4 + T lymphocytes and increases their pathological potential
Journal: Immunity & Ageing : I & A
doi: 10.1186/s12979-025-00526-8
Figure Legend Snippet: Characterization of the senescent CD4 + T lymphocytes. ( a ) Flow cytometry gating strategy used to determine the purity of viable CD4 + T lymphocytes isolated from the spleen of wild-type C57 BL/6 mice. The following sequential gating strategy steps were used: First, cells were physically selected according to their cell size (FSC-A) and internal cell complexity (SSC-A) parameters. Second, only single cells were selected according to their FSC-H and FSC-A characteristics, discarding fused cells as duplets or triplets. Third, dead cells were excluded. Finally, the viable CD4 + T cells were selected for analysis. This cell characterization was performed separately for each animal. (b) Flow cytometry histogram and bar plot show the cell size quantification of viable CD4 + T lymphocytes exposed or non-exposed to oxidative stress (H 2 O 2 ). (c) Flow cytometry histogram and bar plot show the frequency of proliferating CD4 + lymphocytes. H 2 O 2 -exposed CD4 + T cells stimulated with CD3ε-CD28 (red) were compared with non-exposed CD4 + T cells stimulated with CD3ε-CD28 (gray). Non-exposed CD4 + T cells without CD3ε-CD28 stimulation were used as negative control (yellow). The dotted line indicates the reference point used to quantify the proliferating cells. (d) Relative quantification of the mRNA expression of the cell cycle inhibitors p16 Ink4a and p21 Cip1 in H 2 O 2 -exposed or non-exposed CD4 + T cells determined by RT-qPCR. (e) Western blot immunodetection of phospho-p38, total p38, and β-actin and quantification of the phospho-p38/total p38 band density in senescent and non-senescent CD4 + T lymphocytes. (f) Quantification of total p38/β-actin band density in senescent and non-senescent CD4 + T lymphocytes. Data are expressed as mean ± SD. Statistical analysis was performed using the unpaired Student’s t-test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Techniques Used: Flow Cytometry, Isolation, Negative Control, Quantitative Proteomics, Expressing, Quantitative RT-PCR, Western Blot, Immunodetection
Figure Legend Snippet: p38 MAPK in dysfunctional mitochondria accumulation and autophagy disruption in senescent CD4 + T lymphocytes. ( a ) Flow cytometry histogram and bar plot showing the MitoTracker dye MFI in senescent CD4 + T lymphocytes exposed to BIRB-796 or DMSO. Non-senescent CD4 + T lymphocytes were used for comparison. (b) Relative quantification of the mRNA expression of the fusion/fission markers MFN2 and DRP1 in senescent CD4 + T lymphocytes exposed to BIRB-796 or DMSO determined by RT-qPCR. (c) Flow cytometry histogram and bar plot showing the MitoTracker dye MFI in senescent CD4 + T lymphocytes exposed to BIRB-796, BIRB-796 plus Bafilomycin (autophagy inhibitor), Rapamycin (autophagy inducer), or DMSO. The histogram blue peak corresponds to senescent CD4 + T lymphocytes exposed to BIRB-796, the pink peak to senescent CD4 + T lymphocytes exposed to BIRB-796 plus Bafilomycin, the grey peak to senescent CD4 + T lymphocytes exposed to Rapamycin, the red peak to senescent CD4 + T lymphocytes exposed to DMSO, and the yellow peak to the negative control (MitoTracker dye MFO). (d) The same analysis described in (c) using the frequency of MitoTracker high senescent CD4 + T lymphocytes. (e) Flow cytometry histogram and bar plot showing the frequency of MitoSox-positive cells and MitoSox dye MFI in senescent CD4 + T lymphocytes exposed to BIRB-796 or DMSO. Non-senescent CD4 + T lymphocytes were used for comparison. (f) Flow cytometry histogram and bar plot showing the H2DCFDA dye MFI in senescent CD4 + T lymphocytes exposed to BIRB-796 or DMSO. Non-senescent CD4 + T lymphocytes were used for comparison. In all flow cytometry histograms, the blue peak corresponds to senescent CD4 + T lymphocytes exposed to BIRB-796, the red peak to senescent CD4 + T lymphocytes exposed to DMSO, the grey peak to non-senescent CD4 + T lymphocytes, and the yellow peak to the negative controls (MitoTracker, MitoSox, and H2DCFDA dye MFO, respectively). Data are expressed as mean ± SD. Statistical analysis was performed using the unpaired Student’s t-test, when comparing two groups, or the one-way ANOVA and Tukey post hoc tests, when comparing more than two experimental groups. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Baf, bafilomycin; DMSO, dimethyl sulfoxide; H2DCFDA, 2′,7′-dichlorodihydrofluorescein diacetate reagents; MFI, mean fluorescence intensity, MFO: fluorescence minus one; Rap, rapamycin
Techniques Used: Disruption, Flow Cytometry, Comparison, Quantitative Proteomics, Expressing, Quantitative RT-PCR, Negative Control, Fluorescence
Figure Legend Snippet: Role of p38 MAPK in the Th17-type SASP release in senescent CD4 + T lymphocytes. ( a ) Quantification of the secreted levels of IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-23, and GM-CSF in senescent and non-senescent CD4 + T lymphocytes determined by ELISA-Multiplex. (b) Relative quantification of the mRNA expression of RORγt, Tbx 21, STAT-4, and CCL4 in senescent and non-senescent CD4 + T lymphocytes determined by RT-qPCR. (c) Quantification of the secreted levels of IL-6, IL-17A, and GM-CSF in senescent CD4 + T lymphocytes exposed to BIRB-796 or DMSO. (d) Relative quantification of the mRNA expression of RORγt and Tbx 21 in senescent CD4 + T lymphocytes exposed to BIRB-796 or DMSO. (e) Flow cytometry and bar plots showing the number and frequency of senescent CD4 + T lymphocytes exposed to BIRB-796, exposed to DMSO, and non-senescent CD4 + T lymphocytes expressing IL-17A (CD4 + IL-17A + T cells). Data are expressed as mean ± SD. Statistical analysis was performed using the unpaired Student’s t-test. ** p < 0.01, *** p < 0.001, **** p < 0.0001. CCL, chemokine ligand; DMSO, dimethyl sulfoxide; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL, interleukin; ROR, retinoid-related orphan receptor; SASP, senescence-associated secretory phenotype; STAT, signal transducer and activator of transcription; Tbx, T-box transcription factor
Techniques Used: Enzyme-linked Immunosorbent Assay, Multiplex Assay, Quantitative Proteomics, Expressing, Quantitative RT-PCR, Flow Cytometry
Figure Legend Snippet: Graphic summary that contextualizes the main findings of the present study. Activation of p38 MAPK drives cellular senescence in CD4 + T lymphocytes. Particularly, p38 MAPK activation causes mitophagy disruption, accumulation of dysfunctional mitochondria, and production of an SASP enriched in Th17-type mediators. These cell-senescent phenomena were inhibited when BIRB-796 was used to neutralize the p38 MAPK activation
Techniques Used: Activation Assay, Disruption
